Sensitivity analysis in cost-effectiveness studies: from guidelines to practice (Q37851945)

24 August 2017

1 reference

title

Sensitivity analysis in cost-effectiveness studies: from guidelines to practice (English)

1 reference

cost-effectiveness analysis

24 August 2017

1 reference

Rahul Jain

1

1 reference

PubMed ID

21395350

24 August 2017

Michael Grabner

series ordinal

2

1 reference

PubMed ID

21395350

24 August 2017

Eberechukwu Onukwugha

series ordinal

3

1 reference

24 August 2017

1 April 2011

1 reference

24 August 2017

1 reference

24 August 2017

29

1 reference

24 August 2017

4

1 reference

24 August 2017

297-314

1 reference

https://scigraph.springernature.com/pub.10.2165/11584630-000000000-00000

24 August 2017

0 references

cites work

Foundations of Cost-Effectiveness Analysis for Health and Medical Practices

1 reference

https://api.crossref.org/works/10.2165%2F11584630-000000000-00000

Using effectiveness and cost-effectiveness to make drug coverage decisions: a comparison of Britain, Australia, and Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11584630-000000000-00000

Handling uncertainty in cost-effectiveness models

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11584630-000000000-00000

Good practice guidelines for decision-analytic modelling in health technology assessment: a review and consolidation of quality assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11584630-000000000-00000

Sensitivity analysis in economic evaluation: an audit of NICE current practice and a review of its use and value in decision-making.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11584630-000000000-00000

Assessing quality in decision analytic cost-effectiveness models. A suggested framework and example of application

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11584630-000000000-00000

Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices--Modeling Studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11584630-000000000-00000

Health economic guidelines--similarities, differences and some implications

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11584630-000000000-00000

Sensitivity analysis in economic evaluation: a review of published studies

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11584630-000000000-00000

Methodologic quality of cost-effectiveness analyses of surgical procedures.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11584630-000000000-00000

Cost-effectiveness and cost-benefit analyses in the medical literature. Are the methods being used correctly?

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11584630-000000000-00000

The quality of reporting in published cost-utility analyses, 1976-1997.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11584630-000000000-00000

Raising the quality of cost-utility analyses: lessons learnt and still to learn

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11584630-000000000-00000

Use of pharmacoeconomics in prescribing research. Part 5: modelling--beyond clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11584630-000000000-00000

The Markov process in medical prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11584630-000000000-00000

Discounting and health benefits

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11584630-000000000-00000

Impact of model, methodological, and parameter uncertainty in the economic analysis of vaccination programs

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11584630-000000000-00000

The measurement of patients' values in medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11584630-000000000-00000

Measurement of health state utilities for economic appraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11584630-000000000-00000

Something old, something new, something borrowed, something blue: a framework for the marriage of health econometrics and cost-effectiveness analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11584630-000000000-00000

Uncertainty and patient heterogeneity in medical decision models.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11584630-000000000-00000

Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11584630-000000000-00000

Evidence synthesis, parameter correlation and probabilistic sensitivity analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11584630-000000000-00000

Probabilistic sensitivity analysis incorporating the bootstrap: an example comparing treatments for the eradication of Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11584630-000000000-00000

Thinking outside the box: recent advances in the analysis and presentation of uncertainty in cost-effectiveness studies

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11584630-000000000-00000

Efficient tests for normality, homoscedasticity and serial independence of regression residuals

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11584630-000000000-00000

Some Tests for Homoscedasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11584630-000000000-00000

Autoregressive Conditional Heteroscedasticity with Estimates of the Variance of United Kingdom Inflation

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11584630-000000000-00000

The use of economic evaluations in NHS decision-making: a review and empirical investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11584630-000000000-00000

Statistical approaches to handling uncertainty in health economic evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11584630-000000000-00000

Cost-effectiveness of assertive community treatment for homeless persons with severe mental illness

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11584630-000000000-00000

Lessons from trial-based cost-effectiveness analyses of mental health interventions: why uncertainty about the outcome, estimate and willingness to pay matters.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11584630-000000000-00000

A Simple Test for Heteroscedasticity and Random Coefficient Variation

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11584630-000000000-00000

Time preference for health in cost-effectiveness analysis

21 January 2018

1 reference

12 December 2020

Sensitivity analysis in health economic and pharmacoeconomic studies. An appraisal of the literature

1 reference

12 December 2020

Characterizing structural uncertainty in decision analytic models: a review and application of methods

1 reference

12 December 2020

Health economic evaluations using decision analytic modeling. Principles and practices--utilization of a checklist to their development and appraisal

1 reference

12 December 2020

Users' guides to the medical literature. XIII. How to use an article on economic analysis of clinical practice. A. Are the results of the study valid? Evidence-Based Medicine Working Group

1 reference

12 December 2020

Handling uncertainty when performing economic evaluation of healthcare interventions

1 reference

12 December 2020

Probabilistic sensitivity analysis using Monte Carlo simulation. A practical approach

1 reference

12 December 2020

Subgroups and heterogeneity in cost-effectiveness analysis

1 reference

12 December 2020

Towards a European consensus on conducting and reporting health economic evaluations--a report from the ISPOR Inaugural European Conference

1 reference

12 December 2020

How often do sensitivity analyses for economic parameters change cost-utility analysis conclusions?

1 reference

12 December 2020

Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party

1 reference

12 December 2020

10.2165/11584630-000000000-00000

Identifiers

DOI

1 reference

24 August 2017

1 reference

PubMed ID

21395350